AxoSim, Inc. acquired the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary in October 2023. The microBrain™ technology provides a physiologically relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing. The organoid platform replicates important human CNS biology, containing cortical neurons and astrocytes that self-organize and form functional networks in 3D. The hallmark of the microBrain™ organoids is their remarkably consistent performance, making them ideal for high-throughput neurotoxicology, neuromodulation, and drug discovery investigations. For more information about microBrain™ contact sales@axosim.com
Looking for a particular StemoniX employee's phone or email?
The StemoniX annual revenue was $6.8 million in 2026.
1 people are employed at StemoniX.
StemoniX is based in Maple Grove, Minnesota.
The NAICS codes for StemoniX are [5417, 541, 54, 54171, 541714].
The SIC codes for StemoniX are [87, 873].